hosted by

Nicoletta Biglia

Academic Division of Gynecology and Obstetrics. Mauriziano Umberto Ist Hospital. 
The University of Torino Medical School - Torino Italy.
Nicoletta Biglia MD, PhD, is a Full Professor of Gynaecology and Obstetrics at the University of Torino Medical School. She is Director of the Academic Division of Obstetrics and Gynaecology and Breast diseases at the Mauriziano Umberto I Hospital in Torino.
Dr Biglia graduated in Medicine and Surgery at the University of Turin in 1986 summa cum laude. She specialised in Obstetrics and Gynaecology in 1990; she was awarded the PhD degree in Gynaecological Oncology in 1995 and the European Certificate in Laparoscopic Pelvic Surgery in the year 2000.
She primarily devoted her clinical activity to diagnosing and treating breast and pelvic cancer, with a particular interest in hereditary tumours treatment and prevention.
She has developed particular research and clinical interest in the relationship between hormones, oncogenes and breast cancer risk, and innovative surgical techniques both in pelvic and breast oncology to reduce the impact of cancer and cancer-related treatments on the quality of life of survivors.
She has more than 20 years of experience in radical pelvic surgery, oncoplastic breast cancer surgery, in minimally invasive surgery. She has refined her skills through several residencies and visits to Reference Institutions in Europe and the USA.
Dr Biglia has promoted and participated in many international clinical trials in the fields of Gynaecological Oncology, Menopause and Breast Cancer.
She is a member of both National and International Scientific Societies: European Society of Gynaecological Oncology (ESGO), International Gynecologic Cancer Society (IGCS), European Society of Mastology (EUSOMA), Italian Society of Gynaecological Oncology (SIOG), Italian Breast Network (Senonetwork).
She has served on the Board of the Italian Society of Menopause (SIM) for three terms and from 2005 is in the Board of the Italian Society of Gynaecological Oncology (SIOG).
Powered by